Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium hydroxide vs formocresol in root canal therapy for necrotic primary molars
IRCT20180521039763N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of calcium hydroxide and formocresol in pulpitis and Pulp necrosis of deciduous tooth (2 arms), sponsored by Kerman University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
calcium hydroxideformocresol
03
Conditions
pulpitisPulp necrosis of deciduous tooth
Beyond the preview
Go deeper on IRCT20180521039763N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180521039763N1.